Skip to content

Clinical trials

Macular Degeneration trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Country / region: Canada Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20064
20075
20082
20094
20102
20116
20124
20134
20147
20154
20162
20173
20182
20194
20202
20214
20222
20233
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Unknown status14
Terminated11
Recruiting4
Active, not recruiting3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's7
Bayer6
University Health Network, Toronto6
Unity Health Toronto4
Novartis Pharmaceuticals3
OccuLogix3
Regeneron Pharmaceuticals3
GlaxoSmithKline2
Janssen Research & Development, LLC2
McGill University Health Centre/Research Institute of the McGill University Health Centre2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration73
Geographic Atrophy10
Choroidal Neovascularization9
Wet Macular Degeneration7
Retinal Degeneration5
Vision Disorders5
Eye Diseases4
Retinal Diseases4
Retinal Vein Occlusion4
Macular Edema3

Trials

Showing 26 to 50 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.